Figure 3 | Blood Cancer Journal

Figure 3

From: Expression of p89c-Mybex9b, an alternatively spliced form of c-Myb, is required for proliferation and survival of p210BCR/ABL-expressing cells

Figure 3

Half-life of p89c-Mybex9b in K562 cells. Representative western blot shows levels of p75c-Myb and p89c-Mybex9b in: (a) cells treated with cycloheximide only and (c) cells pre-treated for 16 h with 2 μM IM before cycloheximide treatment. Levels of β-actin were measured as loading control. (b–d) Densitometric analysis from two combined experiments assessing the half-life of c-Myb isoforms.

Back to article page